
Mark A. Williams
Examiner (ID: 7190, Phone: (571)272-7064 , Office: P/3675 )
| Most Active Art Unit | 3675 |
| Art Unit(s) | 3676, 3674, 3626, 3673, 3209, 3675, 3722 |
| Total Applications | 2093 |
| Issued Applications | 1531 |
| Pending Applications | 115 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19050883
[patent_doc_number] => 20240092852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => MULTI-ARMED MYXOMA VIRUS
[patent_app_type] => utility
[patent_app_number] => 18/459209
[patent_app_country] => US
[patent_app_date] => 2023-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18459209
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/459209 | MULTI-ARMED MYXOMA VIRUS | Aug 30, 2023 | Pending |
Array
(
[id] => 19020209
[patent_doc_number] => 20240076380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => DEVICE AND METHODS FOR RAPIDLY SCREENING AND TREATING CLINICAL CANCER PATIENTS WITH IMMUNOREGULATORY DRUGS
[patent_app_type] => utility
[patent_app_number] => 18/455557
[patent_app_country] => US
[patent_app_date] => 2023-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455557
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/455557 | DEVICE AND METHODS FOR RAPIDLY SCREENING AND TREATING CLINICAL CANCER PATIENTS WITH IMMUNOREGULATORY DRUGS | Aug 23, 2023 | Pending |
Array
(
[id] => 19064852
[patent_doc_number] => 20240099278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/236218
[patent_app_country] => US
[patent_app_date] => 2023-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18236218
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/236218 | GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF | Aug 20, 2023 | Pending |
Array
(
[id] => 18903063
[patent_doc_number] => 20240018548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => GENE-THERAPY VECTORS FOR TREATING CARDIOMYOPATHY
[patent_app_type] => utility
[patent_app_number] => 18/452495
[patent_app_country] => US
[patent_app_date] => 2023-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18452495
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/452495 | GENE-THERAPY VECTORS FOR TREATING CARDIOMYOPATHY | Aug 17, 2023 | Pending |
Array
(
[id] => 19034516
[patent_doc_number] => 20240084331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => Methods and Systems for Guide RNA Design and Use
[patent_app_type] => utility
[patent_app_number] => 18/235281
[patent_app_country] => US
[patent_app_date] => 2023-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18235281
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/235281 | Methods and Systems for Guide RNA Design and Use | Aug 16, 2023 | Pending |
Array
(
[id] => 20480561
[patent_doc_number] => 12529032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => Methods and culture substrates for controlled induction of biomimetic neural tissues comprising singular rosette structures
[patent_app_type] => utility
[patent_app_number] => 18/448674
[patent_app_country] => US
[patent_app_date] => 2023-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 16
[patent_no_of_words] => 16411
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18448674
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/448674 | Methods and culture substrates for controlled induction of biomimetic neural tissues comprising singular rosette structures | Aug 10, 2023 | Issued |
Array
(
[id] => 19051275
[patent_doc_number] => 20240093244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => EUKARYOTIC CELLS FOR PROTEIN MANUFACTURING AND METHODS OF MAKING THEM
[patent_app_type] => utility
[patent_app_number] => 18/351819
[patent_app_country] => US
[patent_app_date] => 2023-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351819
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/351819 | EUKARYOTIC CELLS FOR PROTEIN MANUFACTURING AND METHODS OF MAKING THEM | Jul 12, 2023 | Pending |
Array
(
[id] => 19051176
[patent_doc_number] => 20240093145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => IN VITRO METHODS OF DIFFERENTIATING STEM CELLS INTO NEURONS AND NEURONS GENERATED USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/215490
[patent_app_country] => US
[patent_app_date] => 2023-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18215490
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/215490 | IN VITRO METHODS OF DIFFERENTIATING STEM CELLS INTO NEURONS AND NEURONS GENERATED USING THE SAME | Jun 27, 2023 | Pending |
Array
(
[id] => 19067536
[patent_doc_number] => 20240101962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => COMPOSITIONS AND METHODS FOR ORGANOID GENERATION AND DISEASE MODELING
[patent_app_type] => utility
[patent_app_number] => 18/340537
[patent_app_country] => US
[patent_app_date] => 2023-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18340537
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/340537 | COMPOSITIONS AND METHODS FOR ORGANOID GENERATION AND DISEASE MODELING | Jun 22, 2023 | Abandoned |
Array
(
[id] => 18879438
[patent_doc_number] => 20240002807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/210821
[patent_app_country] => US
[patent_app_date] => 2023-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18210821
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/210821 | DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS | Jun 15, 2023 | Abandoned |
Array
(
[id] => 18895492
[patent_doc_number] => 20240010977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => METHODS FOR ENHANCING THERAPEUTIC EFFICACY OF ISOLATED CELLS FOR CELL THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/327092
[patent_app_country] => US
[patent_app_date] => 2023-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18327092
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/327092 | METHODS FOR ENHANCING THERAPEUTIC EFFICACY OF ISOLATED CELLS FOR CELL THERAPY | May 31, 2023 | Pending |
Array
(
[id] => 18895224
[patent_doc_number] => 20240010709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => METHODS FOR PREPARING MAMMALIAN CELLS FOR PERFUSION CELL CULTURE
[patent_app_type] => utility
[patent_app_number] => 18/201904
[patent_app_country] => US
[patent_app_date] => 2023-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18201904
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/201904 | METHODS FOR PREPARING MAMMALIAN CELLS FOR PERFUSION CELL CULTURE | May 24, 2023 | Pending |
Array
(
[id] => 18709484
[patent_doc_number] => 20230332101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => ACCELERATION OF STEM CELL DIFFERENTIATION
[patent_app_type] => utility
[patent_app_number] => 18/322105
[patent_app_country] => US
[patent_app_date] => 2023-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18322105
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/322105 | ACCELERATION OF STEM CELL DIFFERENTIATION | May 22, 2023 | Pending |
Array
(
[id] => 19020181
[patent_doc_number] => 20240076352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => Chimeric Antigen Receptor
[patent_app_type] => utility
[patent_app_number] => 18/321400
[patent_app_country] => US
[patent_app_date] => 2023-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18321400
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/321400 | Chimeric Antigen Receptor | May 21, 2023 | Abandoned |
Array
(
[id] => 19096382
[patent_doc_number] => 20240115609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => METHODS FOR EXPANDING AND ACTIVATING yo T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
[patent_app_type] => utility
[patent_app_number] => 18/319677
[patent_app_country] => US
[patent_app_date] => 2023-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18319677
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/319677 | Methods for expanding and activating gs T cells for the treatment of cancer and related malignancies | May 17, 2023 | Issued |
Array
(
[id] => 20730449
[patent_doc_number] => 12637698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-26
[patent_title] => Methods and compositions for targeted genetic modification using paired guide RNAs
[patent_app_type] => utility
[patent_app_number] => 18/317465
[patent_app_country] => US
[patent_app_date] => 2023-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 41
[patent_no_of_words] => 58338
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18317465
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/317465 | Methods and compositions for targeted genetic modification using paired guide RNAs | May 14, 2023 | Issued |
Array
(
[id] => 18771119
[patent_doc_number] => 20230365929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => METHOD OF DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO RETINAL PIGMENT EPITHELIUM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/195849
[patent_app_country] => US
[patent_app_date] => 2023-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18195849
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/195849 | METHOD OF DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO RETINAL PIGMENT EPITHELIUM CELLS | May 9, 2023 | Pending |
Array
(
[id] => 20593883
[patent_doc_number] => 12577587
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Compositions and methods for mammalian genetics and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/128994
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 56
[patent_no_of_words] => 33712
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18128994
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/128994 | Compositions and methods for mammalian genetics and uses thereof | Mar 29, 2023 | Issued |
Array
(
[id] => 18691039
[patent_doc_number] => 20230321230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => Compositions and Methods for Adjuvanted Vaccines
[patent_app_type] => utility
[patent_app_number] => 18/190068
[patent_app_country] => US
[patent_app_date] => 2023-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18190068
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/190068 | Compositions and Methods for Adjuvanted Vaccines | Mar 23, 2023 | Pending |
Array
(
[id] => 18552383
[patent_doc_number] => 20230250392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => MEDIA AND METHODS FOR ENHANCING THE SURVIVAL AND PROLIFERATION OF STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/184517
[patent_app_country] => US
[patent_app_date] => 2023-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18184517
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/184517 | MEDIA AND METHODS FOR ENHANCING THE SURVIVAL AND PROLIFERATION OF STEM CELLS | Mar 14, 2023 | Pending |